US Stem Cell Inc (USRM)

[docprep]

You mean we have $100,000,000+ in R&D

a product who has been clinically trialled to perform better than the competition,

A $5M investment commitment

RMAT approval coming any minute

No contravertible debt

Increased revenues, decreasing expenditures


And a current buy in price under .13c



Geez...if I didn't know better, I'd say i should buy in or buy more

Oh right...just did. ..

;)